EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes

Gabrielė Žaliukaitė, Noura Lebbar

Journal of Clinical Medicine · 13.04.2026 · 15 (8) · 2944

DOI: 10.3390/jcm15082944 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.04.2026. Verfasst von Gabrielė Žaliukaitė und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide-1 (GLP-1) is an incretin hormone involved in glucose regulation. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used in the treatment of type 2 diabetes mellitus and obesity, as well as in cardiovascular risk reduction. Recent evidence suggests that GLP-1 receptors are expressed in cutaneous tissues; however, their role in skin homeostasis and aging remains insufficiently clarified. This review summarizes recent experimental and clinical studies examining the effects of GLP-1 receptor agonists on skin homeostasis, wound healing, regeneration, and aging processes. Experimental data indicate that GLP-1 RAs may promote wound healing through modulation of inflammatory pathways, enhancement of keratinocyte migration, improved microvascular perfusion, and support of fibroblast function. Antioxidant and cytoprotective mechanisms have also been described. Conversely, rapid weight loss associated with GLP-1 RA therapy has been linked to structural facial changes, including reduction in dermal white adipose tissue and decreased collagen synthesis, which may clinically resemble accelerated skin aging. Mechanistic findings suggest heterogeneous and pathway-dependent effects. Overall, the impact of GLP-1 receptor agonists on skin biology appears multifaceted, and further well-designed clinical studies are required to determine their precise dermatological implications.

Schlagwörter

Stichwörter der Autor:innen

adipose-derived stem cellsdermal white adipose tissueglucagon-like peptide-1 receptor agonistsskin agingskin homeostasisskin regenerationwound healing

Autor:innen und Institutionen

  • Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
  • Aesthetic Medicine, University of Genoa, 16126 Genoa, Italy.

Zitieren

APA

Žaliukaitė, G., & Lebbar, N. (2026). Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes. Journal of Clinical Medicine, 15(8), 2944. https://doi.org/10.3390/jcm15082944

Vancouver

Žaliukaitė G, Lebbar N. Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes. Journal of Clinical Medicine. 2026;15(8):2944. doi:10.3390/jcm15082944

BibTeX
@article{aliukait2026,
  author = {Žaliukaitė, Gabrielė and Lebbar, Noura},
  title = {Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {2944},
  doi = {10.3390/jcm15082944}
}
Kostenlos starten →